After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Glaukos Corporation is listed on the NYSE in the Healthcare sector while operating in the Medical Devices industry. The current market capitalization of Glaukos Corporation is $4.97B. A total of 0.97 million shares were traded on the day, compared to an average of 933.53K shares.
In the most recent transaction, Navratil Tomas sold 517 shares of GKOS for 84.22 per share on Sep 22 ’25. After the transaction, the CHIEF DEVELOPMENT OFFICER now owns 76,390 company shares. In a previous transaction on Sep 22 ’25, Navratil Tomas bought 517 shares at 84.22 per share.
Among the insiders who sold shares, Navratil Tomas disposed of 5,142 shares on Sep 11 ’25 at a per-share price of $88.22. This resulted in the CHIEF DEVELOPMENT OFFICER holding 75,469 shares of GKOS after the transaction. In another insider transaction, Navratil Tomas bought 5,142 shares at $88.22 per share on Sep 11 ’25.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, GKOS has a high of $163.71 and a low of $77.10.
As of this writing, GKOS has an earnings estimate of -$0.26 per share for the current quarter. EPS was calculated based on a consensus of 15.0 estimates, with a high estimate of -$0.2 per share and a lower estimate of -$0.31. The company reported an EPS of -$0.28 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. GKOS’s latest balance sheet shows that the firm has $414.05M in Cash & Short Term Investments as of fiscal 2021. There were $382.38M in debt and $63.36M in liabilities at the time. Its Book Value Per Share was $13.36, while its Total Shareholder’s Equity was $587.15M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GKOS is Buy with a score of 4.50.
